Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bioteque Corporation (4107:TWSE), powered by AI.
Bioteque Corporation is currently trading at $116.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Bioteque Corporation on Alpha Lenz.
View Bioteque Corporation's valuation metrics on Alpha Lenz.
“Bioteque Corporation's ROE is 15.3%. Explore profitability and growth together.”
Ask for details →Bioteque Corporation is a leading Taiwanese manufacturer specializing in medical devices, particularly disposable products essential for hemodialysis access, endovascular treatment, and other healthcare applications. Established in 1991 and headquartered in Taipei, Bioteque serves the global healthcare sector by producing items such as hemodialysis bloodline sets, AV fistula needles, IV infusion bags and sets, surgical drainage tubes, catheters, and a variety of medical components and homecare products. These products are distributed internationally, reaching markets across Asia, Europe, the Americas, and Africa. Renowned for its commitment to quality, the company operates multiple advanced manufacturing facilities accredited under ISO 13485 and compliant with FDA and GMP standards. As a publicly listed entity since 2002, Bioteque Corporation plays a significant role in the health technology industry by supporting hospitals, clinics, and health systems with critical single-use medical solutions and by continually investing in research and development to expand its innovative product portfolio.
“Bioteque Corporation's ROE is 15.3%. Explore profitability and growth together.”
Ask for details →Bioteque Corporation (ticker: 4107) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).
The current price is 116.5 with a P/E ratio of -x and P/B of -x.
ROE is 15.30% and operating margin is 31.39%. Annual revenue is $2.1B.